AU2014232540A1
|
|
Polyalkylene oxide valerate hemoglobin conjugates
|
US2013327677A1
|
|
Packaging system for preserving a nonoxygenated hemoglobin based oxygen therapeutic product
|
KR20140144262A
|
|
Succinimide-activated nitroxyl compounds and methods for the use thereof for nitroxylation of proteins
|
KR20150009533A
|
|
Diaspirin crosslinked pegylated hemoglobin
|
WO2013016598A2
|
|
Methods for reducing reperfusion injury using a hemoglobin-based carbon monoxide carrier
|
CN102859364A
|
|
Methods for preparing peg-hemoglobin conjugates using reduced reactant ratios
|
US2013041134A1
|
|
Methods for preparing polyethylene glycol maleimide using n-(2-hydroxyethyl) maleimide as a starting material
|
US2010075379A1
|
|
Method for making polyalkylene oxide modified hemoglobin
|
CA2600927A1
|
|
Compositions and methods for delivering carbon monoxide (co) and nitric oxide (no) to tissue using heme proteins as carriers
|
WO2006026735A2
|
|
Apparatuses and methods for analyzing gas exchange properties of biological fluids
|
AU2005279780A1
|
|
Methods to enhance hemodynamic stability using oxygen carrying compositions
|
BRPI0514713A
|
|
Methods for Increasing Hemodynamic Stability Using Oxygen Carrier Compositions
|
WO2005099858A1
|
|
Methods and compositions for simultaneously isolating hemoglobin from red blood cells and inactivating viruses
|
US2005164915A1
|
|
Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
|
WO03059287A2
|
|
Methods and compositions for oxygen transport comprising an oxygen carrier and a crystalloid in hypertonic solution
|
EP1894573A2
|
|
Methods and compositions for oxygen transport comprising a high oxygen affinity
|
AU2003207503A1
|
|
Methods and compositions for oxygen transport comprising modified hemoglobin in plasma
|
CN1630527A
|
|
Methods and compositions for oxygen transport comprising a high oxygen affinity
|
EP1121165A1
|
|
Method for production of stroma-free hemoglobin
|
US6773613B1
|
|
Method for production of stroma-free hemoglobin
|